InvestorsHub Logo
Followers 27
Posts 2742
Boards Moderated 0
Alias Born 03/17/2017

Re: None

Wednesday, 06/06/2018 9:32:18 AM

Wednesday, June 06, 2018 9:32:18 AM

Post# of 6217
Curious, very interesting.

Got that hint from my peer, big drop on nothing
after the drop of the last legacy AVIR drug bad data.

Reposting some findings, quite interesting.
Sadly missed the dip yesterday, now watching.

+++

VXRT (NASDAQ), since 2018-02-09, was AVIR before

OS
- 2015-09-30 3.51M
- 2018-02-13 7.10M
- 2018-05-11 7.14M (10-Q 1Q18) AS 200M

Fully diluted ~ 8.36M (Strike >= $15/sh)

RS
- 2018-02-13 1:11

Conversion
- 2018-03-31 1.22M Warrants & Options, Strike >= $15/sh

Cash
- 2018-03-31 $17.50M -> $2.45/sh @ 7.14M

Equity
- 2018-03-31 $31.11M -> $4.36/sh @ 7.14M
Total Current Assets > Total Liabilities - Net Net Positive

+++

- 2017-10-27 http://vaxart.com/NRfiles/VaxartAnnouncesInfluenzaPhase2Results.pdf(edited)
- 2017-10-30 Noro VXA-G1.1-NN http://vaxart.com/NRfiles/VaxartAnnouncesNorovirusPhase1bResults.pdf(edited)
- https://clinicaltrials.gov/ct2/results?cond=&term=+Vaxart&cntry1=&state1=&recrs=
- Pipeline http://vaxart.com/images/pipeline.png

- FLU entering ph3 2H18 (payed for by BARDA grant),
- Noro entering ph2 soon

Napkin Math:
- Influenca $3B market size
- Noro $4B market size
- $7000M x 0.01 penetration x 0.46 margin x 0.60 (40% discount) = $19.32M .. $2.72/sh at P/E 1

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VXRT News